Capundag, Samuel M.

HRN: 29-33-79  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/26/2026
08/01/2026
IV
4.5G
Q6
Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: